Véronique Meignin

6.5k total citations
111 papers, 3.6k citations indexed

About

Véronique Meignin is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Véronique Meignin has authored 111 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Oncology, 36 papers in Pathology and Forensic Medicine and 22 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Véronique Meignin's work include Viral-associated cancers and disorders (37 papers), Lymphoma Diagnosis and Treatment (30 papers) and Histiocytic Disorders and Treatments (19 papers). Véronique Meignin is often cited by papers focused on Viral-associated cancers and disorders (37 papers), Lymphoma Diagnosis and Treatment (30 papers) and Histiocytic Disorders and Treatments (19 papers). Véronique Meignin collaborates with scholars based in France, United States and Belgium. Véronique Meignin's co-authors include Lionel Galicier, Éric Oksenhendler, Laurence Gérard, Anne Janin, F. Agbalika, Sylvie Chevret, Emmanuelle Boulanger, Claire Fieschi, Abdellatif Tazi and Pauline Brice and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Véronique Meignin

98 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Véronique Meignin France	35	1.9k	1.3k	598	581	565	111	3.6k
Susan L. Abbondanzo United States	35	1.7k 0.9×	1.4k 1.1×	266 0.4×	398 0.7×	432 0.8×	89	3.8k
Russell K. Brynes United States	35	1.1k 0.6×	913 0.7×	1.0k 1.7×	755 1.3×	401 0.7×	105	3.3k
Thomas G. Gross United States	37	2.1k 1.1×	1.4k 1.1×	974 1.6×	1.0k 1.8×	121 0.2×	127	4.3k
Josée Audouin France	29	1.5k 0.8×	1.3k 1.1×	175 0.3×	394 0.7×	268 0.5×	110	2.8k
Andishe Attarbaschi Austria	33	942 0.5×	980 0.8×	1.1k 1.9×	327 0.6×	139 0.2×	155	3.4k
Véronique Minard‐Colin France	30	874 0.5×	943 0.7×	541 0.9×	669 1.2×	113 0.2×	149	3.5k
Silvia Montoto United Kingdom	41	2.8k 1.5×	3.1k 2.4×	1.4k 2.4×	785 1.4×	211 0.4×	165	5.2k
Norbert Frickhofen Germany	27	882 0.5×	883 0.7×	1.4k 2.4×	559 1.0×	160 0.3×	79	3.8k
O. Fain France	37	430 0.2×	634 0.5×	815 1.4×	888 1.5×	397 0.7×	203	4.2k
Laura C. Bowman United States	42	2.3k 1.2×	628 0.5×	788 1.3×	860 1.5×	163 0.3×	107	5.8k

Countries citing papers authored by Véronique Meignin

Since Specialization

Citations

This map shows the geographic impact of Véronique Meignin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Véronique Meignin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Véronique Meignin more than expected).

Fields of papers citing papers by Véronique Meignin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Véronique Meignin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Véronique Meignin. The network helps show where Véronique Meignin may publish in the future.

Co-authorship network of co-authors of Véronique Meignin

This figure shows the co-authorship network connecting the top 25 collaborators of Véronique Meignin. A scholar is included among the top collaborators of Véronique Meignin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Véronique Meignin. Véronique Meignin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lordello, Leonardo, Isabelle Martins, Jacqueline Lehmann‐Che, et al.. (2025). Metabolic Heterogeneity in Diffuse Large B-Cell Lymphoma Cells Reveals an Innovative Antimetabolic Combination Strategy. Cancers. 17(3). 394–394.

Blasi, Roberta Di, Louise Roulin, Véronique Meignin, et al.. (2025). TRANSCAR: real-world outcomes of CD19 CAR T-cell therapy in relapsed/refractory transformed indolent lymphomas. Blood Advances. 9(18). 4693–4704.

Vercellino, Laëtitia, Estelle Blanc, É. de Kerviler, et al.. (2024). Patterns of metabolic response in patients receiving commercial CAR T-cells for relapsing/refractory aggressive B cells lymphoma. British Journal of Radiology. 97(1163). 1755–1764.

Ghelfenstein-Ferreira, Théo, François Caméléna, Véronique Meignin, et al.. (2024). Unmasking Bartonella henselae infection in the shadows of long COVID thanks to clinical metagenomics. European Journal of Clinical Microbiology & Infectious Diseases. 43(5). 1025–1029. 4 indexed citations

Thieblemont, Catherine, François‐Xavier Gros, Sandrine Roulland, et al.. (2024). Carmod, an Open-Label, Multicenter, Proof of Concept, Phase II Trial, Investigating the Safety and Efficacy of Golcadomide in Post-CART for Patients with Relapsed/Refractory High-Risk Aggressive Large B-Cell Lymphoma. Blood. 144(Supplement 1). 7226–7226.

Ganesan, Saravanan, Evelyne Lauret, Nabih Maslah, et al.. (2024). Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms. Blood Cancer Journal. 14(1). 1–1. 5 indexed citations

Gérard, Laurence, Jehane Fadlallah, Lionel Galicier, et al.. (2023). Higher rate of progression in HIV– than in HIV+ patients after rituximab for HHV8+ multicentric Castleman disease. Blood Advances. 7(18). 5663–5669. 2 indexed citations

Masson, Adèle de, Constance de Margerie‐Mellon, É. de Kerviler, et al.. (2021). Image‐guided lymph node core‐needle biopsy predicts survival in mycosis fungoides and Sézary syndrome*. British Journal of Dermatology. 185(2). 419–427. 6 indexed citations

Lemoine, Jean, Florence Morin, Roberta Di Blasi, et al.. (2021). Lenalidomide Exposure at Time of CAR T-Cells Expansion Enhances Response of Refractory/Relapsed Aggressive Large B-Cell Lymphomas. Blood. 138(Supplement 1). 1433–1433. 8 indexed citations

10.

Thiéblemont, Catherine, Sylvie Chevret, Vincent Allain, et al.. (2020). Lenalidomide Enhance CAR T-Cells Response in Patients with Refractory/Relapsed Large B Cell Lymphoma Experiencing Progression after Infusion. Blood. 136(Supplement 1). 16–17. 16 indexed citations

11.

Pagliuca, Simona, David Michonneau, Véronique Meignin, et al.. (2019). Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disease in Patients Who Received Anti-CD20 after Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 25(12). 2490–2500. 9 indexed citations

12.

Morschhauser, Franck, Steven Le Gouill, Pierre Feugier, et al.. (2019). Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study. The Lancet Haematology. 6(8). e429–e437. 61 indexed citations

13.

Hurabielle, Charlotte, Maxime Battistella, C. Ram‐Wolff, et al.. (2018). Cutaneous presentation of adult T-cell leukemia/lymphoma (ATLL). Single-center study on 37 patients in metropolitan France between 1996 and 2016. Annales de Dermatologie et de Vénéréologie. 145(6-7). 405–412. 11 indexed citations

14.

Brosseau, Solenn, V. Gounant, Charles Naltet, et al.. (2017). Lazarus Syndrome With Crizotinib in a Non–Small Cell Lung Cancer Patient With ROS1 Rearrangement and Disseminated Intravascular Coagulation. Clinical Lung Cancer. 19(1). e57–e61. 4 indexed citations

15.

Galicier, Lionel, David Boutboul, Éric Oksenhendler, Claire Fieschi, & Véronique Meignin. (2016). Histiocytose sinusale de Rosai–Dorfman. La Presse Médicale. 46(1). 107–116. 3 indexed citations

16.

Schlemmer, F., Sylvie Chevret, Gwenaël Lorillon, et al.. (2013). Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT). European Respiratory Journal. 42(Suppl 57). P2344–P2344. 1 indexed citations

17.

Bergeron, Anne, Delphine Réa, Vincent Lévy, et al.. (2007). Lung Abnormalities after Dasatinib Treatment for Chronic Myeloid Leukemia. American Journal of Respiratory and Critical Care Medicine. 176(8). 814–818. 116 indexed citations

18.

Murata, Hideyuki, Anne Janin, Christophe Lebœuf, et al.. (2006). Donor-derived cells and human graft-versus-host disease of the skin. Blood. 109(6). 2663–2665. 48 indexed citations

19.

Gérard, Laurence, Lionel Galicier, Emmanuelle Boulanger, et al.. (2003). Improved survival in HIV-related Hodgkin's lymphoma since the introduction of highly active antiretroviral therapy. AIDS. 17(1). 81–87. 70 indexed citations

20.

Ionescu, Irina, Pauline Brice, D. Simon, et al.. (2000). Restaging with gallium scan identifies chemosensitive patients and predicts survival of poor-prognosis mediastinal Hodgkin's disease patients. Medical Oncology. 17(2). 127–134. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact